LUPUS NEPHRITIS
Clinical trials for LUPUS NEPHRITIS explained in plain language.
Never miss a new study
Get alerted when new LUPUS NEPHRITIS trials appear
Sign up with your email to follow new studies for LUPUS NEPHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising kidney drug trial halted early – what it means for patients
Disease control TerminatedThis study tested a drug called ravulizumab in 123 adults with kidney inflammation caused by lupus or IgA nephropathy. The goal was to see if it could reduce protein in the urine, a sign of kidney damage. The trial was stopped early, so results are limited, but the data may help …
Matched conditions: LUPUS NEPHRITIS
Phase: PHASE2 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 04:03 UTC
-
Lupus kidney drug trial halted midway
Disease control TerminatedThis study tested a drug called zetomipzomib in people with active lupus nephritis, a kidney disease caused by lupus. The goal was to see if the drug could improve kidney function better than a placebo over 52 weeks. The trial was terminated early, so results are limited. Partici…
Matched conditions: LUPUS NEPHRITIS
Phase: PHASE2 • Sponsor: Kezar Life Sciences, Inc. • Aim: Disease control
Last updated May 26, 2026 03:50 UTC
-
Promising kidney drug trial halted early – what it means for patients
Disease control TerminatedThis study tested a drug called ALXN2050 in 100 adults with kidney inflammation caused by lupus or IgA nephropathy. The goal was to see if it could reduce protein in the urine, a sign of kidney damage. Participants took the drug or a placebo for up to 50 weeks. The trial was stop…
Matched conditions: LUPUS NEPHRITIS
Phase: PHASE2 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 12, 2026 13:42 UTC